Experimental High Cholesterol Drug
Regeneron appears to have taken another step forward towards getting the green light for its experimental high cholesterol drug candidate as the FDA has granted a quick review of evicanumab. Those dealing with high cholesterol levels due to a rare genetic disorder often struggle to keep their levels in check even with multiple lipid busting …